Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03562767 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 Diabetes
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03562767: Clinical Trial NA study, sponsored by Emory University.
NCT03562767 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03562767, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The main purpose of the study is to assess the feasibility and acceptability of a Culturally-Tailored Cognitive Behavior intervention (CT-CB) for African American patients with uncontrolled Type 2 diabetes. After the baseline visit subjects will be randomly assigned to undergo a six session group-based or web-based behavioral intervention (CT-CB) program or to general education (usual care). The intervention duration is 12 weeks.
Primary Outcome
Feasibility of the intervention will be measured as the percentage of participants who complete the study. The intervention will be considered feasible if no more than 20% of participants are lost to follow up.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Group-based Cognitive Behavioral Intervention
- BEHAVIORAL Web-based Cognitive Behavioral Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2019-05-30 |
| Phase | NA |
Why NCT03562767 stopped before completion
NCT03562767 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT03562767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03562767 about?
NCT03562767 is a clinical study titled "Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 Diabetes". The main purpose of the study is to assess the feasibility and acceptability of a Culturally-Tailored Cognitive Behavior intervention (CT-CB) for African American patients with uncontrolled Type 2 diabetes. After the baseline visit subjects will be randomly assigned to undergo a six session group-ba...
What is the current status of trial NCT03562767?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2018-12-05. Estimated completion is 2019-05-30.
What interventions are being tested in trial NCT03562767?
The interventions under investigation include: Usual Care (BEHAVIORAL), Group-based Cognitive Behavioral Intervention (BEHAVIORAL), Web-based Cognitive Behavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03562767?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03562767's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI